-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

Benzinga·11/05/2026 15:03:33
Listen to the news
Wells Fargo analyst Stan Berenshteyn maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $37 to $38.